Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
TWST | US
0.57
0.99%
Healthcare
Diagnostics & Research
31/03/2024
26/07/2024
58.08
58.62
60.90
57.03
Twist Bioscience Corporation a synthetic biology company manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products including synthetic genes tools for sample preparation antibody libraries for drug discovery and development and DNA as a digital data storage medium. The company has collaboration agreements with Victorian Clinical Genetic Services; Vivlion GmbH.; Kyowa Kirin Pharmaceutical Research Inc.; deepCDR Biologics AG; and Centogene N.V to develop advanced sequencing tools. It also has a research collaboration with Boehringer Ingelheim International GmbH to use proprietary antibody libraries to discover therapeutic antibodies against multiple targets. The company was incorporated in 2013 and is headquartered in South San Francisco California.
View LessPositive Momentum
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Strong Revenue Growth (> 10%)
Strong Sharpe Ratio (> 1.2)
High 6-Month Volatility (>65%)
Midcap (2B - 10B USD)
High Market Beta (> 0.8)
High Short percentage (> 15%)
Weak Operating Margin (< 10%)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
61.5%1 month
49.5%3 months
82.9%6 months
72.9%-
-
3.01
0.16
0.13
-9.02
5.93
-
-161.18M
3.38B
3.38B
-
-64.92
-
25.10
-30.40
7.35
21.51
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
9.17
Range1M
15.29
Range3M
30.58
Rel. volume
0.66
Price X volume
38.70M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Quidel Corporation | QDEL | Diagnostics & Research | 38.91 | 2.61B | 1.75% | n/a | 78.99% |
Myriad Genetics Inc | MYGN | Diagnostics & Research | 27.65 | 2.50B | -0.72% | n/a | 0.00% |
NeoGenomics Inc | NEO | Diagnostics & Research | 14.88 | 1.90B | -1.33% | n/a | 65.86% |
Soleno Therapeutics Inc | SLNO | Diagnostics & Research | 48.48 | 1.79B | 3.26% | n/a | 0.24% |
CareDx Inc | CDNA | Diagnostics & Research | 19.01 | 992.15M | 0.74% | n/a | 12.86% |
Fulgent Genetics Inc | FLGT | Diagnostics & Research | 23.66 | 708.01M | 2.91% | n/a | 1.15% |
Celcuity Inc | CELC | Diagnostics & Research | 18.73 | 657.44M | -2.19% | n/a | 28.36% |
Varex Imaging Corporation | VREX | Diagnostics & Research | 14.62 | 597.31M | -0.75% | 15.43 | 81.83% |
Surmodics Inc | SRDX | Diagnostics & Research | 41.44 | 591.16M | -0.26% | 43.40 | 27.16% |
National Research Corporation | NRC | Diagnostics & Research | 24.66 | 588.81M | -2.18% | 18.98 | 113.88% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
LCI Industries | LCII | Recreational Vehicles | 116.05 | 2.95B | 2.77% | 29.57 | 81.87% |
Cinemark Holdings Inc | CNK | Media - Diversified | 21.99 | 2.69B | 3.19% | 13.70 | 1090.32% |
VeriFone Systems Inc | PAY | Building Products & Equipment | 21.3 | 2.64B | 4.87% | 86.48 | 2.28% |
HNI Corporation | HNI | Building Products & Equipment | 54.5 | 2.58B | 1.04% | 34.06 | 79.49% |
Fox Factory Holding Corp | FOXF | Recreational Vehicles | 52.08 | 2.17B | 2.12% | 26.82 | 65.22% |
Janus International Group Inc. | JBI | Building Products & Equipment | 14.56 | 2.13B | 4.67% | 14.09 | 124.30% |
Lions Gate Entertainment Corp | LGF-B | Media - Diversified | 7.88 | 1.92B | 3.14% | n/a | -1412.86% |
Lions Gate Entertainment Corp | LGF-A | Media - Diversified | 8.52 | 1.90B | 3.27% | n/a | -1412.86% |
Winnebago Industries Inc | WGO | Recreational Vehicles | 60.76 | 1.76B | 2.22% | 21.20 | 56.33% |
Steelcase Inc | SCS | Building Products & Equipment | 14.03 | 1.60B | 1.45% | 17.82 | 69.98% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -9.02 | 10.11 | Cheaper |
Ent. to Revenue | 5.93 | 25.60 | Cheaper |
PE Ratio | - | 39.75 | - |
Price to Book | 3.01 | 66.29 | Cheaper |
Dividend Yield | - | 1.16 | - |
Std. Deviation (3M) | 82.86 | 63.99 | Riskier |
Debt to Equity | 0.16 | 0.46 | Cheaper |
Debt to Assets | 0.13 | 0.36 | Cheaper |
Market Cap | 3.38B | 12.27B | Emerging |